Skip to main content
logo
SELLAS Life Sciences Group, Inc. (SLS)
NASDAQ: SLS · Real-Time Price · USD
11.05
+0.01 (0.09%)
At close: Aug 11, 2026, 4:00 PM EDT
11.15
+0.10 (0.90%)
Pre-market: Aug 12, 2026, 5:32 AM EDT

SLS Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
2,17357777344988
Market Cap Growth
1278.67%650.23%125.88%-29.90%-44.69%6.07%
Enterprise Value
2,035506.3163.9532.3432.3167.2
Last Close Price
11.053.771.041.062.365.53

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
----48.5911.56
PB Ratio
16.218.148.13-4.2710.024.32
P/TBV Ratio
12.445.968.43-15.594.64

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
----32.318.84

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.05-0.060.120.03
Net Debt / Equity Ratio
-1.00-1.00-1.370.22-3.36-1.01
Net Debt / EBITDA Ratio
3.912.510.410.050.390.82
Net Debt / FCF Ratio
4.852.500.370.060.680.79
Asset Turnover
-0000.040.21
Quick Ratio
18.2910.251.470.191.114.31
Current Ratio
18.8310.721.720.231.144.63
Return on Equity (ROE)
-31.13%-66.88%-4147.88%2389.76%-327.81%-85.70%
Return on Assets (ROA)
-31.48%-57.83%-245.71%-278.84%-177.69%-69.15%
Return on Capital Employed (ROCE)
-33.68%-69.60%-2619.53%3627.30%-313.99%-91.97%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Buyback Yield / Dilution
-86.04%-78.18%-120.33%-43.21%-25.29%-94.07%
Total Shareholder Return
-86.04%-78.18%-120.33%-43.21%-25.29%-94.07%
SEC Filings: 10-K · 10-Q